PLRX Pliant Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 5, 2026 10-K/10-Q Ağu 11, 2026
$1,04
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,0252 haftanın en düşüğü
$1,9552 haftanın en yükseği
Piyasa Değeri (MRQ)
$64M
P/E
-0.4
Hisse Başına Kâr
$-2.43
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$2
P/E
-0.4
ROE
-74.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PLRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.03
Piyasa Değeri (MRQ)
$64M
P/E
-0.4
Hisse Başına Kâr
$-2.43
Gelir
$0
ROE
-74.4%
52 Haftlık Aralık
$1–$2
PLRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Pliant Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriPharmaceuticals
çalışanlar49
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02019-12-31 → 2025-12-31
Hisse Başına Kâr$-2.432019-12-31 → 2025-12-31
Serbest Nakit Akışı$-129M2020-12-31 → 2025-12-31
Net kar marjı·2020-12-31 → 2023-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PLRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.45Y ort. ≈-4.5 | ≈-4.5 | · | · | |
| F/D (MRQ) | 0.45Y ort. ≈2.1 | ≈2.1 | 3.7 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.95Y ort. ≈-6.2 | ≈-6.2 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.95Y ort. ≈-6.3 | ≈-6.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.45Y ort. ≈2.1 | ≈2.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PLRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -48.0%5Y ort. ≈-43.7% | ≈-43.7% | -59.6% | En üst düzey | |
| ROE | -74.4%5Y ort. ≈-52.5% | ≈-52.5% | -74.4% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PLRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.95Y ort. ≈13.7 | ≈13.7 | 2.9 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 11.75Y ort. ≈13.4 | ≈13.4 | 2.6 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PLRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -83.7%5Y ort. ≈-45.9% | ≈-45.9% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -66.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PLRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.0 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.86%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $-0.36 | $-0.35 | -3.2% |
| 31 Mart 2026 | May 6, 2026 | $-0.32 | $-0.36 | 12.0% |
| 31 Aralık 2025 | $-0.38 | $-0.39 | 1.5% | |
| 30 Eylül 2025 | $-0.43 | $-0.53 | 19.5% | |
| 30 Haziran 2025 | $-0.71 | $-0.71 | -0.10% | |
| 31 Mart 2025 | $-0.92 | $-0.74 | -24.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2M | $10M | $8M | $42M | $57M | |
| R&D Expense | $109M | $169M | $128M | $97M | $78M | $66M | $47M | |
| SG&A Expense | $47M | $59M | $58M | $40M | $28M | $17M | $11M | |
| Operating Expenses | $156M | $228M | $186M | $137M | $105M | $83M | $58M | |
| Operating Income | $-156M | $-228M | $-184M | $-127M | $-98M | $-42M | $-1M | |
| Interest Expense | · | · | $1M | $791.0K | $0 | · | · | |
| Interest Income | · | · | · | · | · | $478.0K | $816.0K | |
| Other Non-op | · | · | · | · | · | $-366.0K | $-216.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-149M | $-210M | $-161M | $-123M | $-97M | $-42M | $-631.0K | |
| EPS (Basic) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | |
| EPS (Diluted) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | |
| Shares (Basic) | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 | 1,623,358 | |
| Shares (Diluted) | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 | 1,623,358 | |
| EBITDA | $-156M | $-228M | $-184M | $-127M | · | $-42M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $71M | $63M | $34M | $52M | $51M | $86M | |
| Short-term Investments | $145M | $285M | $431M | $298M | $149M | $226M | $17M | |
| Receivables | · | · | $0 | $2M | $2M | $9M | $7M | |
| Prepaid Expense | $4M | $7M | $11M | $7M | $7M | $4M | $2M | |
| Current Assets | $196M | $362M | $506M | $340M | $209M | $291M | $112M | |
| PP&E (Net) | $3M | $6M | $4M | $4M | $5M | $4M | $4M | |
| PP&E (Gross) | $14M | $16M | $12M | $11M | $10M | $8M | $6M | |
| Accum. Depreciation | $11M | $11M | $9M | $7M | $5M | $3M | $2M | |
| Other Non-current Assets | $392.0K | $435.0K | $392.0K | $394.0K | $838.0K | $451.0K | $3M | |
| Total Assets | $225M | $397M | $512M | $351M | $221M | $296M | $119M | |
| Accounts Payable | $480.0K | $6M | $5M | $2M | $3M | $2M | $1M | |
| Accrued Liabilities | $10M | $12M | $10M | $9M | $12M | $10M | $7M | |
| Current Liabilities | $16M | $33M | $29M | $24M | $17M | $12M | $8M | |
| Capital Leases | $28M | $29M | $0 | $3M | $5M | $0 | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $866.0K | $912.0K | |
| Total Liabilities | $44M | $93M | $39M | $37M | $22M | $12M | $9M | |
| Long-term Debt | $0 | $30M | $10M | $10M | $0 | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-859M | $-710M | $-500M | $-338M | $-215M | $-118M | $-76M | |
| AOCI | $-15.0K | $321.0K | $345.0K | $-2M | $-201.0K | $-32.0K | $-1.0K | |
| Stockholders' Equity | $181M | $304M | $474M | $313M | $199M | $283M | $-76M | |
| Liabilities + Equity | $225M | $397M | $512M | $351M | $221M | $296M | $119M | |
| Shares Outstanding | 61,449,290 | 60,860,838 | 59,921,002 | 48,941,254 | 36,083,301 | 35,552,795 | 1,846,024 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $26M | $38M | $44M | $23M | $10M | $4M | $2M | |
| Operating Cash Flow | $-128M | $-156M | $-116M | $-95M | $-75M | $-37M | $-3M | |
| CapEx | $374.0K | $4M | $921.0K | $2M | $2M | $2M | $964.0K | |
| Investing Cash Flow | $134M | $140M | $-127M | $-150M | $74M | $-211M | $-18M | |
| Financing Cash Flow | $-32M | $23M | $274M | $227M | $3M | $213M | $46M | |
| Net Change in Cash | $-26M | $8M | $31M | $-18M | $783.0K | $-35M | $25M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | $-129M | $-159M | $-117M | $-96M | · | $-39M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -11654.8% | -1313.4% | · | -99.6% | · | |
| Net Margin | · | · | -10211.1% | -1273.3% | · | -99.3% | · | |
| EBITDA Margin | · | · | -11654.8% | -1313.4% | · | -99.6% | · | |
| ROA | -48.0% | -46.3% | -37.4% | -43.1% | · | -20.0% | · | |
| ROE | -74.4% | -64.7% | -33.0% | -37.9% | · | -14.2% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 10.9 | 17.7 | 14.2 | · | 25.1 | · | |
| Quick Ratio | 11.7 | 10.7 | 17.3 | 13.9 | · | 24.7 | · | |
| Interest Coverage | · | · | -145.3 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | · | |
| Receivables Turnover | · | · | 1.6 | 4.9 | · | 5.1 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.95 | $5.00 | $7.90 | $6.40 | · | $7.96 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.03 | $0.23 | · | $1.96 | · | |
| Cash Flow / Share | $-2.09 | $-2.57 | $-1.98 | $-2.25 | · | $-1.75 | · | |
| Cash / Share | $0.74 | $1.17 | $1.06 | $0.69 | · | $1.43 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | · | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| EPS (TTM) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -83.7% | 27.9% | -81.9% | · | · | |
| Revenue CAGR 3Y | · | · | -66.4% | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $2M | $10M | $8M | $42M | · | |
| Net Income TTM | $-149M | $-210M | $-161M | $-123M | $-97M | $-42M | · | |
| Market Cap | $75M | $802M | $1.09B | $946M | · | $808M | · | |
| P/E | -0.5 | -3.8 | -6.6 | -6.6 | -5.0 | -11.7 | · | |
| P/S | · | · | 686.8 | 97.7 | · | 19.3 | · | |
| P/B | 0.4 | 2.6 | 2.3 | 3.0 | · | 2.9 | · | |
| P / Tangible Book | 0.4 | 2.6 | 2.3 | 3.0 | · | 2.9 | · | |
| P / Cash Flow | -0.6 | -5.2 | -9.3 | -10.0 | · | -21.7 | · | |
| P / FCF | -0.6 | -5.0 | -9.3 | -9.8 | · | -20.8 | · | |
| Earnings Yield | -199.2% | -26.4% | -15.2% | -15.2% | -20.1% | -8.6% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $248.0K | $1M | $1M | $5M | |
| R&D Expense | $17M | $14M | $16M | $18M | $32M | $43M | $39M | $48M | $46M | $37M | $33M | $32M | $33M | $29M | $25M | $26M | |
| SG&A Expense | $7M | $8M | $8M | $10M | $13M | $15M | $15M | $14M | $15M | $15M | $14M | $15M | $15M | $14M | $9M | $8M | |
| Operating Expenses | $24M | $22M | $24M | $28M | $46M | $59M | $53M | $62M | $61M | $52M | $47M | $48M | $48M | $43M | $33M | $35M | |
| Operating Income | $-24M | $-22M | $-24M | $-28M | $-46M | $-59M | $-53M | $-62M | $-61M | $-52M | $-47M | $-48M | $-47M | $-42M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $445.0K | · | $317.0K | $319.0K | $311.0K | $301.0K | $173.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-22M | $-20M | $-24M | $-26M | $-43M | $-56M | $-50M | $-58M | $-56M | $-47M | $-41M | $-41M | $-41M | $-38M | $-31M | $-30M | |
| EPS (Basic) | $-0.36 | $-0.32 | $-0.37 | $-0.43 | $-0.71 | $-0.92 | $-0.82 | $-0.95 | $-0.92 | $-0.78 | $-0.68 | $-0.70 | $-0.70 | $-0.67 | $-0.65 | $-0.82 | |
| EPS (Diluted) | $-0.36 | $-0.32 | $-0.37 | $-0.43 | $-0.71 | $-0.92 | $-0.82 | $-0.95 | $-0.92 | $-0.78 | $-0.68 | $-0.70 | $-0.70 | $-0.67 | $-0.65 | $-0.82 | |
| Shares (Basic) | 61,919,233 | 61,803,467 | · | 61,406,475 | 61,386,183 | 61,222,676 | · | 60,730,935 | 60,382,796 | 60,180,921 | · | 59,688,451 | 59,172,869 | 56,057,603 | 46,799,058 | 36,173,135 | |
| Shares (Diluted) | 61,919,233 | 61,803,467 | · | 61,406,475 | 61,386,183 | 61,222,676 | · | 60,730,935 | 60,382,796 | 60,180,921 | · | 59,688,451 | 59,172,869 | 56,057,603 | 46,799,058 | 36,173,135 | |
| EBITDA | $-24M | $-22M | · | $-28M | $-46M | $-59M | · | $-62M | $-61M | $-52M | · | $-48M | $-47M | $-42M | $-32M | $-30M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $22M | $45M | $94M | $87M | $92M | $71M | $80M | $80M | $114M | $63M | $58M | $55M | $103M | $45M | $25M | |
| Short-term Investments | $133M | $149M | $145M | $148M | $176M | $214M | $285M | $325M | $356M | $368M | $431M | $466M | $500M | $475M | $316M | $139M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $3M | $1M | $5M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $5M | $6M | $7M | $6M | $11M | $8M | $11M | $11M | $9M | $8M | $4M | $5M | |
| Current Assets | $163M | $175M | $196M | $246M | $267M | $311M | $362M | $410M | $448M | $490M | $506M | $534M | $566M | $588M | $366M | $174M | |
| PP&E (Net) | $2M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $5M | $6M | $4M | $4M | $4M | $4M | $5M | $5M | |
| PP&E (Gross) | $13M | $13M | $14M | $16M | $17M | $16M | $16M | $16M | $15M | $15M | $12M | $12M | $12M | $11M | $11M | $10M | |
| Accum. Depreciation | $11M | $10M | $11M | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $8M | $8M | $7M | $6M | $6M | |
| Other Non-current Assets | $554.0K | $389.0K | $392.0K | $392.0K | $391.0K | $427.0K | $435.0K | $427.0K | $437.0K | $392.0K | $392.0K | $392.0K | $672.0K | $644.0K | $397.0K | $913.0K | |
| Total Assets | $190M | $203M | $225M | $277M | $300M | $345M | $397M | $446M | $484M | $522M | $512M | $540M | $575M | $598M | $377M | $185M | |
| Accounts Payable | $2M | $362.0K | $480.0K | $485.0K | $1M | $6M | $6M | $7M | $3M | $7M | $5M | $3M | $2M | $1M | $3M | $3M | |
| Accrued Liabilities | $4M | $4M | $10M | $8M | $7M | $7M | $12M | $10M | $8M | $6M | $10M | $8M | $7M | · | $20M | $17M | |
| Current Liabilities | $16M | $10M | $16M | $18M | $21M | $28M | $33M | $40M | $31M | $30M | $29M | $27M | $30M | $23M | $26M | $23M | |
| Capital Leases | $26M | $27M | $28M | $28M | $29M | $29M | $29M | $30M | $30M | $24M | $0 | $0 | $2M | $3M | $4M | $4M | |
| Total Liabilities | $43M | $37M | $44M | $76M | $80M | $88M | $93M | $100M | $91M | $84M | $39M | $37M | $42M | $36M | $40M | $37M | |
| Long-term Debt | $0 | $0 | $0 | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-902M | $-879M | $-859M | $-836M | $-810M | $-766M | $-710M | $-660M | $-603M | $-547M | $-500M | $-459M | $-417M | $-376M | $-303M | $-273M | |
| AOCI | $-397.0K | $-341.0K | $-15.0K | $34.0K | $-1.0K | $159.0K | $321.0K | $848.0K | $-617.0K | $-489.0K | $345.0K | $-2M | $-2M | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $147M | $165M | $181M | $200M | $220M | $257M | $304M | $346M | $393M | $437M | $474M | $503M | $533M | $562M | $337M | $148M | |
| Liabilities + Equity | $190M | $203M | $225M | $277M | $300M | $345M | $397M | $446M | $484M | $522M | $512M | $540M | $575M | $598M | $377M | $185M | |
| Shares Outstanding | 61,920,154 | 61,914,569 | 61,449,290 | 61,449,290 | 61,386,183 | 61,386,183 | 60,860,838 | 60,849,503 | 60,425,144 | 60,318,542 | 59,921,002 | 59,890,980 | 59,222,685 | 58,978,902 | 48,749,842 | 36,182,297 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $6M | $6M | $9M | $8M | $9M | $11M | $10M | $9M | $10M | $13M | $12M | $5M | $3M | |
| Operating Cash Flow | $-13M | $-19M | $-18M | $-21M | $-41M | $-49M | $-48M | $-32M | $-45M | $-30M | $-25M | $-36M | $-25M | $-30M | $-18M | $-24M | |
| CapEx | $0 | $0 | $0 | $0 | $112.0K | $262.0K | $209.0K | $896.0K | $1M | $1M | $61.0K | $94.0K | $603.0K | $163.0K | $696.0K | $254.0K | |
| Investing Cash Flow | $15M | $-4M | $2M | $28M | $35M | $69M | $39M | $31M | $11M | $60M | $32M | $38M | $-23M | $-174M | $-178M | $6M | |
| Financing Cash Flow | $0 | $74.0K | $-32M | $72.0K | $0 | $498.0K | $102.0K | $543.0K | $684.0K | $22M | $219.0K | $699.0K | $161.0K | $273M | $216M | $10M | |
| Net Change in Cash | $3M | $-23M | $-48M | $7M | $-5M | $21M | $-8M | $-770.0K | $-34M | $51M | $7M | $3M | $-48M | $69M | $20M | $-7M | |
| Free Cash Flow | · | $-19M | · | · | · | $-49M | · | · | · | $-32M | · | · | · | $-30M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | -19083.9% | -3160.3% | -2155.7% | -594.1% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | -16609.7% | -2818.9% | -2065.8% | -592.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | -19083.9% | -3160.3% | -2155.7% | -594.1% | |
| ROA | -9.1% | -7.3% | · | -7.3% | -11.1% | -13.0% | · | -11.7% | -10.5% | -8.4% | · | -9.0% | -10.8% | -9.4% | -10.0% | -13.4% | |
| ROE | -12.2% | -9.5% | · | -9.6% | -14.1% | -16.2% | · | -13.6% | -12.1% | -9.4% | · | -9.9% | -12.1% | -10.2% | -11.0% | -15.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | 16.9 | · | 13.9 | 13.0 | 11.0 | · | 10.3 | 14.5 | 16.1 | · | 19.5 | 19.2 | 25.4 | 14.0 | 7.7 | |
| Quick Ratio | 9.6 | 16.5 | · | 13.7 | 12.8 | 10.8 | · | 10.1 | 14.1 | 15.9 | · | 19.1 | 18.9 | 25.1 | 13.8 | 7.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -117.7 | · | -150.4 | -148.4 | -135.4 | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.1 | 0.6 | 1.0 | 1.5 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.37 | $2.67 | · | $3.26 | $3.59 | $4.19 | · | $5.68 | $6.50 | $7.25 | · | $8.40 | $9.00 | $9.53 | $6.91 | $4.08 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.02 | $0.03 | $0.14 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.80 | · | · | · | $-0.50 | · | · | · | $-0.54 | · | · | |
| Cash / Share | $0.40 | $0.36 | · | $1.53 | $1.41 | $1.50 | · | $1.31 | $1.33 | $1.89 | · | $0.96 | $0.93 | $1.74 | $0.92 | $0.69 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| EPS (TTM) | $-1.48 | $-1.83 | · | $-2.88 | $-3.40 | $-3.61 | · | $-3.33 | $-3.08 | $-2.86 | · | $-2.76 | $-2.71 | $-2.83 | $-2.93 | $-3.03 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $248.0K | · | $4M | $5M | $10M | $10M | $10M | |
| Net Income TTM | $-92M | $-113M | · | $-175M | $-207M | $-220M | · | $-202M | $-185M | $-171M | · | $-155M | $-144M | $-133M | $-113M | $-109M | |
| Market Cap | $71M | $78M | · | $91M | $71M | $83M | · | $682M | $650M | $899M | · | $1.04B | $1.07B | $1.57B | $1.02B | $290M | |
| P/E | -0.8 | -0.7 | · | -0.5 | -0.3 | -0.4 | · | -3.4 | -3.5 | -5.2 | · | -6.3 | -6.7 | -9.4 | -7.1 | -2.6 | |
| P/S | · | · | · | · | · | · | · | · | · | 3624.0 | · | 293.0 | 213.5 | 160.6 | 104.8 | 29.4 | |
| P/B | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.3 | · | 2.0 | 1.7 | 2.1 | · | 2.1 | 2.0 | 2.8 | 3.0 | 2.0 | |
| P / Tangible Book | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.3 | · | 2.0 | 1.7 | 2.1 | · | 2.1 | 2.0 | 2.8 | 3.0 | 2.0 | |
| P / Cash Flow | · | -4.1 | · | · | · | -1.7 | · | · | · | -29.7 | · | · | · | -51.8 | · | · | |
| Earnings Yield | -129.8% | -145.2% | · | -194.6% | -293.1% | -267.4% | · | -29.7% | -28.6% | -19.2% | · | -15.9% | -15.0% | -10.6% | -14.0% | -37.8% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $0 | $2M | $10M | $8M |
| Faaliyet Kâr Marjı % | · | · | -11654.8% | -1313.4% | · |
| Net Gelir | $-149M | $-210M | $-161M | $-123M | $-97M |
| Seyreltilmiş Hisse Başı Kâr | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 12.0 | 10.9 | 17.7 | 14.2 | · |
| Cari Oran | 11.7 | 10.7 | 17.3 | 13.9 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-129M | $-159M | $-117M | $-96M | · |
Kurumsal Sahipler (13F) 99 dosya · $56.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
99
Tutulan Değer
$56.9M
Yeni pozisyonlar
12
Çıkan pozisyonlar
12
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 12 (-2 önceki Ç'ye göre) | 12 (-1 önceki Ç'ye göre) | 18 (-8 önceki Ç'ye göre) | 27 (0 önceki Ç'ye göre) | -1.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $7.001.038 | 6.141.261 | 12,30% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $6.281.085 | 5.509.724 | 11,04% | Hisse senetleri |
| VANGUARD GROUP INC | $3.438.255 | 2.818.241 | 6,04% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.782.000 | 2.440.351 | 4,89% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $2.579.628 | 2.262.832 | 4,53% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.442.138 | 2.142.226 | 4,29% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $2.336.856 | 2.049.874 | 4,11% | Hisse senetleri |
| Monaco Asset Management SAM | $2.210.172 | 1.938.747 | 3,88% | Hisse senetleri |
| Lynx1 Capital Management LP | $2.049.800 | 1.798.070 | 3,60% | Hisse senetleri |
| BML Capital Management, LLC | $1.762.596 | 1.546.137 | 3,10% | Hisse senetleri |
| Prosight Management, LP | $1.562.066 | 1.370.233 | 2,74% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $1.519.632 | 1.245.600 | 2,67% | Hisse senetleri |
| Peapod Lane Capital LLC | $1.492.275 | 1.309.013 | 2,62% | Hisse senetleri |
| Woodline Partners LP | $1.478.049 | 1.296.534 | 2,60% | Hisse senetleri |
| BlackRock, Inc. | $1.312.384 | 1.151.214 | 2,31% | Hisse senetleri |
| Ikarian Capital, LLC | $1.140.000 | 1.000.000 | 2,00% | Hisse senetleri |
| Eversept Partners, LP | $1.016.224 | 891.425 | 1,79% | Hisse senetleri |
| MARSHALL WACE, LLP | $952.041 | 835.124 | 1,67% | Hisse senetleri |
| Redmile Group, LLC | $880.224 | 772.126 | 1,55% | Hisse senetleri |
| JPMORGAN CHASE & CO | $783.894 | 681.647 | 1,38% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $733.157 | 643.120 | 1,29% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $659.954 | 578.577 | 1,16% | Hisse senetleri |
| UBS Group AG | $651.806 | 571.760 | 1,15% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $637.770 | 559.447 | 1,12% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $631.138 | 553.630 | 1,11% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $611.132 | 536.081 | 1,07% | Hisse senetleri |
| DAFNA Capital Management LLC | $555.180 | 487.000 | 0,98% | Hisse senetleri |
| XTX Topco Ltd | $502.562 | 440.844 | 0,88% | Hisse senetleri |
| Laurion Capital Management LP | $470.587 | 412.796 | 0,83% | Hisse senetleri |
| TORNO CAPITAL, LLC | $400.647 | 351.445 | 0,70% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $389.596 | 341.751 | 0,68% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $345.420 | 303.000 | 0,61% | Hisse senetleri |
| MORGAN STANLEY | $340.833 | 298.976 | 0,60% | Hisse senetleri |
| SEI INVESTMENTS CO | $338.909 | 297.291 | 0,60% | Hisse senetleri |
| Verdad Advisers, LP | $320.731 | 281.343 | 0,56% | Hisse senetleri |
| ArrowMark Colorado Holdings LLC | $320.555 | 281.189 | 0,56% | Hisse senetleri |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $313.500 | 275.000 | 0,55% | Hisse senetleri |
| STATE STREET CORP | $288.897 | 253.418 | 0,51% | Hisse senetleri |
| Stonepine Capital Management, LLC | $262.813 | 230.538 | 0,46% | Hisse senetleri |
| Rangeley Capital, LLC | $256.500 | 225.000 | 0,45% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $237.787 | 208.585 | 0,42% | Hisse senetleri |
| Congress Wealth Management LLC / DE / | $231.907 | 199.920 | 0,41% | Hisse senetleri |
| Marquette Asset Management, LLC | $198.930 | 174.500 | 0,35% | Hisse senetleri |
| HighMark Wealth Management LLC | $189.495 | 166.224 | 0,33% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $175.232 | 153.712 | 0,31% | Hisse senetleri |
| JANE STREET GROUP, LLC | $148.144 | 129.951 | 0,26% | Hisse senetleri |
| NORTHERN TRUST CORP | $142.568 | 125.060 | 0,25% | Hisse senetleri |
| ALGERT GLOBAL LLC | $140.678 | 123.402 | 0,25% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $131.013 | 114.924 | 0,23% | Hisse senetleri |
| Invesco Ltd. | $119.333 | 104.678 | 0,21% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, TANG CAPITAL PARTNERS, LP, TANG CAPITAL PARTNERS INTERNATIONAL, LP, TANG CAPITAL PARTNERS III, INC, TANG CAPITAL PARTNERS IV, INC, CONCENTRA BIOSCIENCES, LLC | 10 Mart 2025 | 9,60% | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 23 içeriden öğrenenler · 9 yöneticiler · 14 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Bernard Coulie | President and CEO | 17 Nisan 2026 A | 505.601 | 0 | 1 | $-114.400 |
| Keith Lamont Cummings | Chief Financial Officer | 17 Nisan 2026 A | 297.214 | 0 | 1 | $-30.723 |
| Minnie Kuo | Chief Operating Officer | 17 Nisan 2026 A | 37.806 | 0 | 1 | $-8.854 |
| David Raben | Chief Medical Officer | 01 Ekim 2026 A | · | 0 | 0 | $0 |
| Lily Cheung | Chief Human Resource Officer | 17 Nisan 2026 A | 44.847 | 0 | 1 | $-9.644 |
| Mike Ouimette | General Counsel & Corp. Sec'y | 23 Ocak 2025 A | 105.544 | 0 | 0 | $0 |
| Hans Hull | Chief Business Officer | 23 Ocak 2025 A | 251.708 | 0 | 0 | $0 |
| Eric Lefebvre | Chief Medical Officer | 23 Ocak 2025 A | 240.224 | 0 | 0 | $0 |
| Barbara Howes | Chief Human Resource Officer | 23 Ocak 2021 A | 24.799 | 0 | 0 | $0 |
| Flavia Borellini | Yönetim kurulu üyesi | 09 Temmuz 2026 A | · | 0 | 0 | $0 |
| Robert Iannone | Yönetim kurulu üyesi | 09 Temmuz 2026 A | · | 0 | 0 | $0 |
| Steve E. Krognes | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Darren S Cline | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| John T Curnutte | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Thomas A Mccourt | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Hoyoung Huh | Yönetim kurulu üyesi | 11 Haziran 2026 A | 239.619 | 0 | 0 | $0 |
| Gayle A Crowell | Yönetim kurulu üyesi | 11 Haziran 2026 A | · | 0 | 0 | $0 |
| Katharine Knobil | Yönetim kurulu üyesi | 05 Haziran 2025 A | · | 0 | 0 | $0 |
| Suzanne Louise Bruhn | Yönetim kurulu üyesi | 05 Haziran 2025 A | · | 0 | 0 | $0 |
| David E I Pyott | Yönetim kurulu üyesi | 05 Haziran 2025 A | · | 0 | 0 | $0 |
| Smital Shah | Yönetim kurulu üyesi | 13 Haziran 2024 A | · | 0 | 0 | $0 |
| Neil Exter | Yönetim kurulu üyesi | 16 Haziran 2022 A | 0 | 0 | 0 | $0 |
| Charles J Homcy | · | 29 Haziran 2021 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 5 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 205.246 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 21.830 SH | 02 Ekim 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 615.799 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.746.470 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 153.712 SH | 19 Ağustos 2026 | Günlük |
PLRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 10 analist
SAT
Medyan hedef
$2.00
+93,2%
0 0,0%
Güçlü Al
0 0,0%
Al
6 60,0%
Tut
2 20,0%
Sat
2 20,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-10-04Ortalama hedef $2.00 +93,2%
Düşük$2.00
Ortalama$2.00
Yüksek$2.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| NTHI | · | -2.6 | -51.8% | · | · | · |
| TELO | $46M | -4.0 | · | · | -325.7% | · |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | · |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| CING | · | · | · | · | · | · |
| ELOX | · | · | · | · | 30.1% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 11, 2026